Grants Disclosure

Grants Disclosure

As part of the Corporate Integrity Agreement (CIA) entered into between the Office of Inspector General of the Department Of Health And Human Services and Aegerion Pharmaceuticals, Inc. (Aegerion), Aegerion is required to publicly post information related to Grant funding on an annual basis.

In This Section

Home // About Novelion // Grants Disclosure

The table below contains information pertaining to Grants that are subject to disclosure pursuant to the CIA, including the name of the recipient, the name of the program funded, a brief description thereof, and the amount of the grant.

Recipient Program Name Program Description Grant Amount
American Heart Association Scientific Sessions 2017 Dedicated Track on Diabetes, Lipids, and Metabolic Syndrome $10,000
The Familial Hypercholesterolemia Foundation FH Global Summit Support Support for Japanese HCPs to attend 2017 FH Global Summit $14,000
The Familial Hypercholesterolemia Foundation FH Global Summit Support Support for Japanese HCPs to attend 2017 FH Global Summit $2,200

Please direct any questions to ComplianceOffice@Aegerion.com